MORRISVILLE – TrialCard has a new name and brand: Mercalis.
The Triangle-based company that works with life science companies on commercialization efforts, announced the change on Wednesday.
“Commercializing life sciences” is the company’s mission.
“Patient support services are increasingly the foundation upon which many life sciences companies build their commercialization strategies,” said Mercalis CEO Scott Dulitz in the announcement. “Since we already offered market-leading patient support services capabilities, it was logical for us to expand into new areas of commercialization like market access data and healthcare provider engagement. Mercalis helps clients at every stage of development, from strategic consulting that drives key commercialization initiatives, to executional solutions that deliver on our shared mission of enhancing patient lives.”
Mercalis, which launched in 2000, is a portfolio company of Odyssey Investment Partners and has more than 1,800 employees.